YU41923B - Process for preparing a viral vaccine against influenza - Google Patents

Process for preparing a viral vaccine against influenza

Info

Publication number
YU41923B
YU41923B YU1265/80A YU126580A YU41923B YU 41923 B YU41923 B YU 41923B YU 1265/80 A YU1265/80 A YU 1265/80A YU 126580 A YU126580 A YU 126580A YU 41923 B YU41923 B YU 41923B
Authority
YU
Yugoslavia
Prior art keywords
preparing
vaccine against
against influenza
viral vaccine
viral
Prior art date
Application number
YU1265/80A
Other versions
YU126580A (en
Inventor
K Brown
R C Stewart
Original Assignee
Cutter Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21904398&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=YU41923(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Cutter Lab filed Critical Cutter Lab
Publication of YU126580A publication Critical patent/YU126580A/en
Publication of YU41923B publication Critical patent/YU41923B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/543—Mucosal route intranasal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16211—Influenzavirus B, i.e. influenza B virus
    • C12N2760/16234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Mycology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
YU1265/80A 1979-05-15 1980-05-13 Process for preparing a viral vaccine against influenza YU41923B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US3923679A 1979-05-15 1979-05-15

Publications (2)

Publication Number Publication Date
YU126580A YU126580A (en) 1983-12-31
YU41923B true YU41923B (en) 1988-02-29

Family

ID=21904398

Family Applications (1)

Application Number Title Priority Date Filing Date
YU1265/80A YU41923B (en) 1979-05-15 1980-05-13 Process for preparing a viral vaccine against influenza

Country Status (13)

Country Link
EP (1) EP0019218B2 (en)
JP (1) JPS55153723A (en)
AR (1) AR220838A1 (en)
AT (1) ATE16454T1 (en)
AU (1) AU535804B2 (en)
CA (1) CA1122527A (en)
DE (1) DE3071225D1 (en)
DK (1) DK154749C (en)
ES (1) ES8104405A1 (en)
IL (1) IL60063A0 (en)
NO (1) NO801443L (en)
RO (1) RO79525B (en)
YU (1) YU41923B (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5753489A (en) * 1994-11-10 1998-05-19 Immuno Ag Method for producing viruses and vaccines in serum-free culture
US5698433A (en) * 1994-11-10 1997-12-16 Immuno Ag Method for producing influenza virus and vaccine
US6146873A (en) * 1994-11-10 2000-11-14 Baxter Aktiengesellschaft Production of orthomyxoviruses in monkey kidney cells using protein-free media
DE69535940D1 (en) * 1994-11-10 2009-06-04 Baxter Healthcare Sa Process for the production of biological products in protein-free culture
JPH11509081A (en) * 1994-11-16 1999-08-17 セント ジュード チルドレンズ リサーチ ホスピタル New replication process
DE19612967A1 (en) * 1996-04-01 1997-10-02 Behringwerke Ag Process for the propagation of influenza viruses in cell culture, and the influenza viruses obtainable by the process
DE19612966B4 (en) 1996-04-01 2009-12-10 Novartis Vaccines And Diagnostics Gmbh & Co. Kg MDCK cells and methods of propagating influenza viruses
DE10144906B4 (en) 2001-09-12 2013-11-28 Novartis Vaccines And Diagnostics Gmbh Process for the large-scale production of vaccines
US6830917B2 (en) * 2001-12-10 2004-12-14 Baxter Healthcare S.A. Method of isolation and purification of trypsin from pronase protease and use thereof
EP2923711A1 (en) 2004-11-03 2015-09-30 Novartis Vaccines and Diagnostics, Inc. Influenza vaccination
EP2022849A4 (en) * 2006-05-11 2010-10-06 Chemo Sero Therapeut Res Inst Method for proliferation of influenza virus
US8506966B2 (en) 2008-02-22 2013-08-13 Novartis Ag Adjuvanted influenza vaccines for pediatric use
TW201012930A (en) * 2008-06-16 2010-04-01 Intervet Int Bv Method of replicating viruses in suspension
EA201500910A1 (en) 2009-02-10 2016-04-29 Новартис Аг VACCINES AGAINST FLU WITH REDUCED NUMBER OF SQUALES

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2262962B1 (en) * 1974-03-05 1977-11-04 Science Union & Cie

Also Published As

Publication number Publication date
YU126580A (en) 1983-12-31
IL60063A0 (en) 1980-07-31
RO79525A (en) 1984-07-17
ES491517A0 (en) 1981-04-01
NO801443L (en) 1980-11-17
DK212580A (en) 1980-11-16
EP0019218B2 (en) 1995-03-01
CA1122527A (en) 1982-04-27
RO79525B (en) 1984-09-30
EP0019218A3 (en) 1981-03-25
DK154749B (en) 1988-12-19
JPS55153723A (en) 1980-11-29
DE3071225D1 (en) 1985-12-19
ATE16454T1 (en) 1985-11-15
DK154749C (en) 1989-05-16
JPH0124769B2 (en) 1989-05-15
AR220838A1 (en) 1980-11-28
AU5824480A (en) 1980-11-20
EP0019218B1 (en) 1985-11-13
ES8104405A1 (en) 1981-04-01
EP0019218A2 (en) 1980-11-26
AU535804B2 (en) 1984-04-05

Similar Documents

Publication Publication Date Title
PT77977A (en) Process for preparing a coupled h.influenza type b vaccine
PT71926A (en) Process for preparing a liquid vaccine comprising a stabilizer
EG13530A (en) A process for preparing imidazolderivates
PT70446A (en) Process for preparation a aqueous lubrificant
YU126580A (en) Process for preparing a viral vaccine against influenza
PT71044A (en) A process for preparing mercaptoacyldipeptides
PT68831A (en) Process for the preparation of a pneumococcal vaccine
PT70452A (en) Process for preparing a spiro-polycyclicimidazolidinedionederivative
DE3064479D1 (en) Process for preparing a b30-threonine insulin
HU179290B (en) Process for preparing vaccine against poultry pest
EP0004793A3 (en) Process for preparing 2-aminopyrimidones, intermediate 2-nitroaminopyrimidones and a process for their preparation
DE2962494D1 (en) A process for preparing lysergol derivatives
DE3377972D1 (en) A process for producing a hepatitis b infection preventing vaccine
ZA804107B (en) A process for preparing aldehydes
GB2065473B (en) Process for producing hepatitis b vaccine
PT69522A (en) Process for preparing a quinazoline derivative
DE3063984D1 (en) A process for preparing a diarylamine
PT70604A (en) Process for the preparing of a record receiving sheet
IL58947A0 (en) Vaccines against viral illnesses
PT67632B (en) Process for the preparation of a respiratory syncytial vaccine
CH611518A5 (en) Process for the preparation of a virus subunit vaccine
YU35479A (en) Process for preparing a new sodium alumoglucoheptonate
PT71822B (en) Process for preparing vaccine for dental caries
PH14990A (en) Process for producing a vaccine
YU103079A (en) Process for preparing a trisazo-dye